Preclinical
BPC-157
BPC-157 is a synthetic 15-residue peptide, a partial sequence related to a protein in human gastric juice. It is stable as a peptide in experimental work and it is not an approved drug.
Research summary only. Not medical advice, not a protocol, and not for human or veterinary consumption.
- Also called
- Body protection compound-157, PL-14736, Bepecin
- CAS
- 137525-51-0
- Formula
- C62H98N16O22
- Mass
- 1419.5 g/mol (free peptide)
- Sequence or structure
- GEPPPGKPADDAGLV
- Evidence
- Preclinical
Mechanism
Animal papers describe effects on gastric mucosa, tendon, and other tissues, and they propose cytoprotective and pro-angiogenic signalling. Those are experimental observations. They are not a map of what a given vial will do, and they are not a reason to take it.
Evidence
The public record is dominated by rodent and in-vitro studies, much of it from one research community. Controlled human evidence sufficient for approval does not exist. PubChem lists the free peptide as CID 9941957, CAS 137525-51-0.
Limitations
Acetate and other salts are heavier than the free peptide, so a label that says 10 mg is ambiguous until the salt is named. A certificate that omits the salt has skipped the fact that determines peptide content. Not for human use. Anti-doping lists often catch non-approved substances; that is a status, not a suggestion.
